Posts Tagged ‘
Big pharma ’
Mar 24th, 2009 |
By Marc Lichtenfeld |
Category: Stock Market Investing, Top Story
With so many biotech stocks making big moves and pharmaceutical merger activity moving faster than anything else right now, we turned to one of the smartest analysts in the lucrative biotech field to give us his take on what we should be doing…
Tags: Amgen, Big pharma, Biotech Sector, Biotech Stocks, gilead sciences, Marc Lichtenfeld, Pfizer, Pharmaceutical Merger, Small Cap
Posted in Stock Market Investing, Top Story |
No Comments »
Jan 6th, 2009 |
By Andrew Snyder |
Category: Stock Market Investing
Reading between the lines is key to successful stock market investing today, says Andrew Snyder. Pfizer’s (NYSE:PFE) announcement that it is looking to acquire rival companies in 2009 signals that organic growth will be hard to come by. And that’s bad news for shareholders. Andrew says savvy investors can bet against the company by short selling or buying put options.
Tags: Andrew Snyder, bear market, Big pharma, Mergers And Acquisitions, Pfe, put options, short selling, US stocks
Posted in Stock Market Investing |
1 Comment »
Nov 19th, 2008 |
By Patrick Cox |
Category: Featured
New breakthroughs in adult stem cell technology offer staggering implications for medical science, says Patrick Cox. And a massive opportunity for investors. As Big Pharma move in, Patrick says biotech companies involved in stem cell research and RNA technology could become the “investment of a lifetime.”
Tags: Big pharma, Biotech Stocks, hot stock picks, Patrick Cox, Pfe, Pfizer, stem cell research
Posted in Featured |
No Comments »
Nov 6th, 2008 |
By Martin Hutchinson |
Category: Featured
Martin Hutchinson analyses what a Democrat landslide means for investors. He says nuclear and clean energy stocks, auto manufacturers, generic drug producers and muni bonds are a “buy”. But fossil fuel companies and financial institutions should be avoided.
Tags: Alternative Energy, Auto Companies, Barack Obama, Big Oil, Big pharma, Biotech Stocks, carbon permits, coal-fired plants, ETFs, Ford Motor Co., generic drugs, Gm, investment strategies, Martin Hutchinson, minu bonds, Nuclear Energy, Obamanomics, pharmaceutical stocks, President Obama, Solar Energy, US Election, US recession, US stocks, Wind Energy
Posted in Featured |
No Comments »
May 30th, 2008 |
By Dr. George Huang |
Category: Stock Market Investing
In 2007, the Maryland lottery had a record year. It pulled in more than $1.5 billion of revenue… $50 million went toward running lottery operations, $110 million to retailers, $500 million to the state, and winners collected the remaining $900 million.
Tags: alzheimer drug, Big pharma, biotech, Flurizan, Lundbeck, Myriad Genetics, US stocks
Posted in Stock Market Investing |
No Comments »
May 23rd, 2008 |
By Rob Fannon |
Category: International Investing
One of the drug industry’s biggest superstars right now is a cancer drug called Sutent.
Tags: , Big pharma, Cancer Drugs, Fda, Genentech, International Investing, Nexavar, Oil Sands, Onyx Pharmaceuticals, penny Stock, Pfizer
Posted in International Investing |
No Comments »
May 2nd, 2008 |
By Rob Fannon |
Category: US Dollar & Forex Trading
Back in December, my friend Steve Sjuggerud described a British spending spree taking place in America. At the time, the pound was worth about $1.95, and Brits were enjoying a 50% discount on their Christmas shopping across the pond.
Tags: Big pharma, Biotech Investors, Biotech Stocks, dollar, falling dollar, Glaxosmithkline, Great Science, GSK, pharma stocks, Sirtris Pharmaceuticals, Us Stock Market, Weak Dollar
Posted in US Dollar & Forex Trading |
No Comments »
Apr 18th, 2008 |
By Dr. George Huang |
Category: International Investing
The Japanese have gone on a shopping spree. In the last six months, two of Japan’s biggest drugmakers in have scooped up two midsized U.S. biotech firms at nothing short of whopping valuations. This international binge bodes well for us biotech investors.
Tags: Big pharma, biotech, Eisai, Japan, Mgi Pharma, Millennium Pharmaceuticals, Takeda Pharmaceuticals
Posted in International Investing |
No Comments »
Apr 11th, 2008 |
By Dr. George Huang |
Category: Stock Market Investing
Back in December, I told you the bleak story of Neurocrine Biosciences (NBIX). A week earlier, the company had received a crushing blow from the FDA, dished out in a notorious “approvable letter.” Approvable letters are the FDA’s way of turning a “yes/no” decision on a new drug into a “maybe.”
Tags: Big pharma, biotech, Dividends, NBIX, Pfizer, US stocks
Posted in Stock Market Investing |
No Comments »
Apr 9th, 2008 |
By Justice Litle |
Category: International Investing
Cash McDash is on a roll. Just don’t give him grief over his new nickname. There is an art to making money in bear market rallies. Cash explains. Is this China-based pharma company a great buy… a great short… or none of the above?
Tags: , Big pharma, Blackstone Bx, GFA, JASO, LDK, Ldk Bear Markets, LongTop Financial, Market Rallies, Nasdaq, WX
Posted in International Investing |
No Comments »